Company intelligence / Profile preview

Biowest

Nuaillé-sur-Boutonne, Pays de la Loire, Francebio-west.com ↗

Ownership: Private
Development stage: Other

Overview

Biowest provides a comprehensive range of animal sera and cell culture media used globally in biopharmaceutical production, vaccine manufacturing, academic research, and industrial R&D. The company emphasizes quality control, traceability, ISO certification (9001 & 13485), and vertical integration from raw material collection to finished product delivery. It has been a European leader since 1987 and operates globally with both direct sales and distributor partnerships. No clinical results as it does not develop therapeutics.

Industry: Chemicals & Materials

Partnerships

Distributors worldwide including IM Beit HaEmek in Israel

Beyond the preview

Go deeper on Biowest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biowest.

Explore the full profile